Previous studies have shown that tumors with higher levels of Programmed cell death-Ligand 1(PD-L1) are more malignant and less survivable; besides, suppressing the PD-1/PD-L1 pathway promotes tumor cell survival (Nakanishi et al., 2007; Okudaira et al., 2009). This evidence concerns the gene CD274 and neoplasm.